Aztreonam: review of the clinical experience and potential uses in pediatrics.
Lebel
M H
MH
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
McCracken
G H
GH
D000293:Adolescent; D001398:Aztreonam / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003429:Cross Reactions; D003550:Cystic Fibrosis / Q000150:complications; D004342:Drug Hypersensitivity / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008581:Meningitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000209:etiology; D014552:Urinary Tract Infections / Q000188:drug therapy
D001398:Aztreonam